TNDM
Tandem Diabetes Care Inc.
$14.54
-$0.43(-2.84%)
34
Overall
40
Value
18
Tech
44
Quality
Market Cap
$1.11B
Volume
2.84M
52W Range
$9.98 - $29.65
Target Price
$30.24
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $84.2M | $107.6M | $183.9M | $362.3M | $498.8M | $702.8M | $801.2M | $747.7M | $940.2M | $1.0B | ||
| Total Revenue | $84.2M | $107.6M | $183.9M | $362.3M | $498.8M | $702.8M | $801.2M | $747.7M | $940.2M | $1.0B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-60.7M | $-63.5M | $-94.0M | $168.1M | $238.3M | $326.6M | $388.2M | $380.0M | $450.6M | $468.7M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $23.6M | $44.1M | $89.8M | $194.2M | $260.5M | $376.2M | $413.0M | $367.7M | $489.6M | $546.0M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-101.6M | $-107.0M | $-134.5M | $210.9M | $268.5M | $353.6M | $505.8M | $600.9M | $588.7M | $733.3M | ||
| Research & Development | $18.8M | $20.7M | $29.2M | $45.2M | $63.6M | $92.1M | $170.2M | $248.4M | $198.9M | $268.3M | ||
| Research Expense | $18.8M | $20.7M | $29.2M | $45.2M | $63.6M | $92.1M | $139.1M | $169.7M | $198.9M | $193.1M | ||
| Selling, General & Administrative | $82.8M | $86.4M | $105.2M | $165.7M | $204.9M | $261.5M | $335.7M | $352.5M | $389.8M | $445.0M | ||
| Selling & Marketing Expenses | $82.8M | $86.4M | $105.2M | $900.0K | -- | -- | -- | -- | -- | -- | ||
| General & Administrative Expenses | -- | -- | $-2.6M | $165.7M | $204.9M | $261.5M | $335.7M | $352.5M | $389.8M | $445.0M | ||
| Promotion & Advertising | $-900.0K | $-1.1M | $-900.0K | $900.0K | -- | -- | -- | -- | -- | -- | ||
| Salaries & Wages | $-11.7M | $-12.6M | $-23.7M | $1.3M | $600.0K | $1.0M | -- | -- | -- | -- | ||
| Depreciation & Amortization | $-5.2M | $-6.5M | $-5.5M | $5.7M | $9.2M | $11.7M | $12.3M | $13.8M | $14.7M | -- | ||
| Depreciation & Amortization | $-5.2M | $-6.5M | $-5.5M | $5.7M | $9.2M | $11.7M | -- | -- | -- | -- | ||
| Amortization | $-300.0K | $-2.2M | $-300.0K | $300.0K | $1.2M | $2.2M | $3.9M | $4.1M | $4.0M | -- | ||
| Other Operating Expenses | $-101.6M | $-107.0M | $-134.5M | $-1.1M | $-2.2M | $-3.5M | -- | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-78.1M | $-62.9M | $-44.6M | $-16.7M | $-8.0M | $22.7M | $-92.8M | $-233.2M | $-99.1M | $-187.3M | ||
| EBITDA | $-72.0M | $-52.9M | $-107.4M | $-18.5M | $-13.7M | $34.1M | $-72.3M | $-192.5M | $-65.8M | $-172.8M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $5.7M | $11.3M | $7.6M | $78.0K | $12.2M | $4.3M | $4.3M | $9.9M | $7.4M | $7.9M | ||
| Intinc | $296.0K | $239.0K | $1.5M | $3.2M | $1.6M | $674.0K | $6.1M | $22.9M | $18.0M | -- | ||
| Net Non-Operating Interest Income/Expense | $-5.4M | $-11.1M | $-6.1M | $3.2M | $-11.2M | $-5.4M | $152.0K | $13.0M | $-7.4M | $-7.9M | ||
| Other Income/Expense | $-118.0K | $-1.0M | $71.8M | $11.1M | $17.1M | $1.4M | $-30.9M | $5.0M | $3.4M | $14.2M | ||
| Other Special Charges | -- | $1.0M | $-71.8M | $-11.1M | $-17.1M | $-1.4M | $147.0K | -- | $-1.3M | -- | ||
| SPECIAL ITEMS | ||||||||||||
| Special Income Charges | $927.0K | $1.7M | -- | -- | -- | -- | -- | -- | -- | $-20.0M | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-77.8M | $-61.7M | $-115.0M | $-24.6M | $-24.1M | $20.2M | $-88.5M | $-210.4M | $-84.5M | $-192.4M | ||
| Pre-Tax Income | $-83.5M | $-73.0M | $-122.6M | $-24.6M | $-36.3M | $15.9M | $-92.9M | $-220.3M | $-91.9M | $-200.3M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $-15.0K | $8.0K | $51.0K | $149.0K | $-1.9M | $335.0K | $1.7M | $2.4M | $4.2M | $4.4M | ||
| NET INCOME | ||||||||||||
| Net Income | $-83.4M | $-73.0M | $-245.2M | $-24.8M | $-34.4M | $15.6M | $-94.6M | $-222.6M | $-96.0M | $-204.7M | ||
| Net Income (Continuing Operations) | $-83.4M | $-73.0M | $-245.2M | $-24.8M | $-34.4M | $15.6M | $-94.6M | $-222.6M | $-96.0M | $-204.7M | ||
| Net Income (Discontinued Operations) | $-83.4M | $-73.0M | $-245.2M | $-24.8M | $-34.4M | $15.6M | $-94.6M | $-222.6M | $-96.0M | $-204.7M | ||
| Net Income (Common Stockholders) | $-83.4M | $-73.0M | $-245.2M | $-24.8M | $-34.4M | $15.6M | $-94.6M | $-222.6M | $-96.0M | $-204.7M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-178.3M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-162.3M | $-170.5M | $-228.5M | $379.0M | $506.8M | $680.1M | $894.1M | $980.9M | $1.0B | $1.2B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $3.1M | $5.7M | $48.1M | $58.5M | $61.0M | $63.0M | $64.1M | $65.0M | $65.5M | $67.3M | ||
| Average Shares Outstanding (Diluted) | $3.1M | $5.7M | $48.1M | $58.5M | -- | $64.3M | $64.1M | $65.0M | $65.5M | $67.3M | ||
| Shares Outstanding | $3.1M | $44.7M | $57.7M | $59.7M | $62.5M | $63.9M | $64.5M | $65.6M | $66.5M | $68.3M | ||
| Basic EPS | -- | -- | $0.06 | $-0.42 | $-0.56 | $0.25 | $-1.47 | $-3.43 | $-1.47 | $-3.04 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | $-0.42 | $-0.56 | $0.25 | $-1.47 | $-3.43 | $-1.47 | $-3.04 | ||
| Diluted EPS | $-27.3 | $-12.87 | $-2.55 | $-0.42 | $-0.56 | $0.24 | $-1.47 | $-3.43 | $-1.47 | $-3.04 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | $0.24 | $-1.47 | $-3.43 | $-1.47 | $-3.04 | ||
| OTHER METRICS | ||||||||||||
| Development Expense | -- | -- | -- | -- | -- | -- | $31.0M | $78.8M | -- | $75.2M | ||
| Earnings from equity interest | -- | -- | -- | -- | -- | -- | -- | -- | $-2.1M | $-14.2M | ||
| Earnings From Equity Interest Net Of Tax | -- | -- | -- | -- | -- | -- | -- | -- | $-2.1M | $-14.2M | ||
| Net Income Extraordinary | -- | -- | $-122.6M | $-24.8M | -- | -- | -- | -- | -- | -- | ||
| Non Recurring Operation Expense | -- | -- | -- | -- | -- | -- | -- | -- | -- | $20.0M | ||
| Other Gand A | -- | -- | $-2.6M | $165.7M | $204.9M | $261.5M | $335.7M | $352.5M | $389.8M | $445.0M | ||
| Other Write Off | $-118.0K | $-524.0K | $-646.0K | $855.0K | $2.5M | $1.9M | -- | -- | -- | -- | ||
| Rent And Landing Fees | -- | -- | $-2.6M | -- | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $82.8M | $86.4M | $105.2M | -- | -- | -- | -- | -- | -- | -- | ||
| Othspecchg | $-927.0K | $-1.7M | -- | -- | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TNDM | $14.54 | -2.8% | 2.84M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Tandem Diabetes Care Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW